https://pmc.ncbi.nlm.nih.gov/articles/PMC3610676/
Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological...
The safety of progestogens as a class has come under increased scrutiny after the publication of data from the Women's Health Initiative trial, particularly...
hormone therapyprogestogensusedpostmenopausaldifferences
https://pmc.ncbi.nlm.nih.gov/articles/PMC10966896/
Use of progestogens and the risk of intracranial meningioma: national case-control study - PMC
To assess the risk of intracranial meningioma associated with the use of selected progestogens. National case-control study. French National Health Data System...
https://pubmed.ncbi.nlm.nih.gov/29570359/
Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal...
Postmenopausal hormone therapy (HT) is a modifiable risk factor for venous thromboembolism (VTE). While the route of estrogen administration is now well...
venous thromboembolism
https://pubmed.ncbi.nlm.nih.gov/11392036/?dopt=Abstract
Estrogen, progestogens and cardiovascular risk
This paper provides an overview of hormone replacement therapy (HRT) and its relationship to cardiovascular risk factors, based on several recent studies that...
estrogenprogestogenscardiovascularrisk
https://hsrc.himmelfarb.gwu.edu/gwhpubs/8252/
"Baseline use of aspirin or statins with oral estrogen and progestogens" by John W. Davis, Aaron K....
OBJECTIVE: To evaluate whether effects of oral hormone therapy (HT) on risks of venous and arterial vascular events differ by baseline statin or aspirin use....
https://pmc.ncbi.nlm.nih.gov/articles/PMC6119173/
Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a...
We systematically reviewed data about the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. Thereafter a...